chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tested positive for COVID 19 after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID 19 after 1st dose) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced COVID-19 (Tested positive for COVID 19 after 1st dose). At the time of the report, COVID-19 (Tested positive for COVID 19 after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Symptomatic break-through case with cough, fatigue,  fever, and shortness of breath, as of 10/3/21. Tested positive on 10/5
This spontaneous report as received from a registered nurse refers to a patient of unknown age. Pertinent medical histories, drug reactions, allergies and concomitant medications were not provided. on 14-AUG-2016 the patient was vaccinated with M-M-R II lot # L024266 and expiry day 01-JUL-2017 (dose, frequency and route of administration were not reported) and therapy for unknown reason which were improperly stored (incorrect product storage). No symptoms reported (no adverse event). There were no previous excursion of temperature. Temperature was 48 F, time frame was 72 hours and no data logger was there. The outcome of incorrect product storage was unknown. This case is linked to case WAES1608USA009124 (same reporter link). Additional information has been requested.
Swelling occurred after taking flu vaccine in (L) arm. No redness and it's not tender to touch. Swelling under (L) arm and into the (L) side of chest into clavicle area.
p/vax pt felt dizzy & ill;next day noticed arm swollen & painful 10/21/99;arm shoulder noted w/swollen, mild erythema;
Exactly 1 week post-vqccination, I began to experience severe itching at the injection site, closely followed by swelling and hardening, redness and tenderness
Patients daughter came in today 1/8/2018 after concern that her mom almost dropped her newborn baby. She stated she was a nurse and thought that when her mom received the vaccine back in November the placement was high on the arm. Her mom complained of pain as to be expected for a few days, but then a week later it continued to increase. She noticed no bruising or swelling just that it continued to worsen to the point were her mom can not lift her arm to a normal level and when she almost dropped her baby today she decided it was time to come in and let us know and as our advice. I advised her that she should have her mom seen by a doctor and she informed she did not have insurance. I tried to follow up this evening and left a voice mail with the daughter.
I went to sleep at 10:00pm and felt totally fine. About 2:00am I would up with fast heart beat with heart burn feeling. I got up to walk around and felt very dizzy. This continued for 15 minutes and I realized it could not be walked off. I don't often go to doctors so this really scared me. Then I went to the Emergency Room.
Pain in arms, wrists, neck, shoulder, back right side of jaw.  Sparks of electrical current down arms and tingling of finger tips, lightheadedness, shortness of breath, chest tightness.
Arm was sore at the injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm was sore at the injection site) and FATIGUE (Fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A, 045A21A and 051F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore at the injection site) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL 8 HOUR) for Adverse event, at a dose of 2 dosage form. At the time of the report, VACCINATION SITE PAIN (Arm was sore at the injection site) and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.   This case was linked to MOD-2021-384391, MOD-2021-384074 (Patient Link).
CANNOT TASTE; CANNOT SMELL; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced cannot taste, and cannot smell. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the cannot taste and cannot smell was not reported. This report was non-serious. This case is a duplicate of 20221237736.
A physician reported that a female, post vax, developed a fever of 104 to 105F, chills, body aches, cough and nasal drainage. A dx of influenza was made; however, the type was not specified.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 2/9/2023 Discharge Date: Feb 15, 2023  PRESENTING PROBLEM: Heart failure (HCC)  Acute systolic congestive heart failure (HCC) Acute respiratory failure with hypoxia (HCC)   HOSPITAL COURSE: Patient is a 101-year-old male with a past medical history of hypertension, hyperlipidemia, coronary artery disease, and severe aortic stenosis who presented with shortness of breath for the past couple of days.  He required 3 L of nasal cannula in the ER and was therefore started on Lasix 40 mg IV in the hospital with concern for acute on chronic diastolic heart failure exacerbation in the setting of severe aortic stenosis.  He was transitioned to lasix 40 mg PO on 02/11/2023.  He had good output on this regimen.  On 02/11/2023, patient was noted to have increased heart rates in the 120s to 130s.  His home dose of 12.5 mg Toprol was increased to 25 mg 2 times a day.  Chest x-ray in the morning of 12/11/2023 demonstrated decreased aeration, persistent mixed interstitial airspace opacities and small pleural effusions.  It appeared worse than prior x-ray performed on 02/09/2023.  An ultrasound of the lung was ordered that demonstrated bilateral pleural effusions.  A repeat chest x-ray on 02/12/2023 demonstrated worsening moderate pulmonary edema superimposed on bilateral pneumonia with increasing pleural effusion.  During this time, patient was also noted tab increasing oxygen requirements requiring venturi mask with FiO2 of 50%.  Diuresis was uptitrated with the assistance of Cardiology began patient on Lasix 80 mg twice a day.  Repeat complete blood count demonstrated leukocytosis with white blood cell count of 17.  Patient was also noted to have elevated inflammatory markers with CRP of 55.  Patient's COVID 19 PCR came back positive 2/11, and patient was subsequently started on remdesivir/Decadron for management of COVID-19.  Palliative Care also saw patient during his hospitalization and eventually contacted hospice in order to discuss goals of care with patient.  Patient eventually elected to sign on with home hospice after discharge from hospital. Patient's diuresis was continued Lasix 80 mg twice daily, and he was eventually able to wean completely off oxygen and tolerate ambulation on room air without oxygen desaturations.  He was subsequently discharged home with hospice on 02/15/2023 in stable condition.
While in observation area, patient complained of racing heart and blood pressure elevation and some shortness of breath.  Evaluated by EMS.  BP 210/115 (average), P98-126.  Able to communicate clearly entire time, some dyspnea but no respiratory distress.  Due to elevated blood pressure and heart rate, she was transported to Hospital for evaluation/treatment.
Patient became almost unresponsive after over 10 minutes of COVID-19 booster administration. Still in standing position but unaware of surroundings. Immediately taken to the clinic inside the store for better observation using store electric scooter. With the help of pharmacist, nurse practitioner and 911 phone instructions, patient started a bit of awareness and taken to the hospital after the 911 arrived. According to the wife, he is in total awareness now and in good condition waiting for further tests and monitoring.
Vaccination was received on December 23, 2020. No immediate adverse effects. Starting on December 31, 2020 I developed a localized inflammation at the injection site. Associated puritis and tenderness. Over the last 24 hours erythema has increased. I have not treated with any compresses or over-the-counter medications.
patient developed shingles.  we tried to explained that this is not a side effect of the vaccine and could be triggered by other things such as stress, surgery, etc. patient called CDC and was told to have the provider office report this to VAERS.
About 2 weeks after I received my shot I became almost lifeless ,my wife had to do every thing for me my body shut down never see or had anything like this before,I had extreme temporarily poleralisysis
PATIENT COMPLAINED OF SWELLING AND INFLAMMATION IN THE  ELBOW OF LEFT ARM EVEN AFTER ALMOST ONE MONTH, BEGINNING WITH THE FIRST DAY AFTER INJECTION
74YM  who presented to the ER  with complaints of dizziness, recurrent falls, and syncope.  EMS found him to be hypotensive and brought him to the emergency room.  Symptoms reportedly started 1 day after his Covid vaccine on 5/7/21 approximately 2 weeks prior to admission.  Patient had COVID-19 infection in 2020.  Patient also endorsed some loose stools over the past several days.  Patient was given IV fluids however his blood pressures remained low in the emergency room.  Infectious and cardiac work-up including bedside echocardiogram were negative and patient had a central line placed in the emergency room and was started on pressors support with norepinephrine drip.  Spot serum cortisol was 6.8 despite shock state.  Patient was transferred to medical facility and started on stress dose steroids with rapid improvement in his symptoms.  Patient was felt to have adrenal crisis with underlying adrenal insufficiency although given his symptoms cortisol stimulation testing was not performed.  Patient was transferred to the hospitalist service out of the ICU on 6/28/2021 and stress dose steroids have been weaned rapidly.  Patient has been started on oral steroids on day of discharge (7/1)  with 20 mg in the a.m. and 10 mg in the p.m. which can be further weaned.  Patient did have MRI brain without contrast which showed normal pituitary size and morphology but unfortunately was without without contrast nothing more can be determined.  Adrenal glands appeared morphologically normal upon CAT scan of the abdomen.  Patient did have acute kidney injury with creatinine upon admission of 6.47 mg/dL.  His baseline creatinine was thought to be 1.6.  By time of discharge creatinine had significantly improved with BUN of 71 and creatinine of 2.  Patient reports improvement in his strength and resolution of dizziness at time of discharge.  Given his low blood pressures his home lisinopril, hydrochlorothiazide, metoprolol have been held.  Would recommend holding hydrochlorothiazide, metoprolol, and enalapril until seen by his PCP or endocrinologist.  We will restart his lisinopril upon discharge as systolic blood pressures have been ranging from 130-160. Discharge home on 7/1/21.
Swelling in my right cheek that has persisted for two days. No other signs of an allergic reaction and no pain with the swelling.
Morning flu vaccination given at vaccination site: Covid-19 Vaccinator for 2021 Flu Vaccine (without Covid-19 shot) on Saturday, Sep 25, 2021 at 10:00 AM.   By evening facial swelling, the next day more extreme swelling, and evening urgent care appointment for Bells Palsy. A recurrence from four years prior, also potentially linked to flu vaccine (around the same time of year).  Steroids (prednisone) prescribed at urgent care Sunday night at 8 pm.
This case was reported by a consumer and described the occurrence of diarrhea in a 31-year-old female subject who was vaccinated with ENGERIX B, (GlaxoSmithKline).  A physician or other health care professional has not verified this report.  On 23 March 2008 at 17:00 the subject received 3rd dose of ENGERIX B (.5 ml, unknown).  The subject received an expired pediatric dose (expiration date: 21 March 2008) of ENGERIX B On 25 March 2008, 2 days after vaccination with ENGERIX B, the subject experienced diarrhea.  At the time of reporting the outcome of diarrhea was unspecified.
Pt received DTAP vaccine on 8/6/12 AM and gradually developed area of erythema and induration measuring 4.6 inches x 6 inches on Left upper arm 8/9/12. Area is warm, itchy and tender to touch.
Pt developed a rash at home, approx. 45 minutes, post vax.
Rashes and hives appearing all over the body. Every day since it started. 10 days after the booster (3rd) Moderna shot. They come and go, disappear and reappear randomly on feet, legs, back, shoulders, neck, head, arms, hands,  Very itchy and burning sensation.   No previous allergy history at all, no change in lifestyle or nutrition, no pets.
This case was reported by a consumer via call center representative and described the occurrence of burning sensation in a 64-year-old female patient who received SHINGRIX for prophylaxis. In September 2018, the patient received the 1st dose of SHINGRIX. In September 2018, 6 hrs after receiving SHINGRIX, the patient experienced burning sensation, generalized pruritus and general body pain. On an unknown date, the patient experienced immunoglobulins increased. On an unknown date, the outcome of the burning sensation, generalized pruritus, general body pain and immunoglobulins increased were unknown. It was unknown if the reporter considered the burning sensation, generalized pruritus, general body pain and immunoglobulins increased to be related to SHINGRIX. Additional details were provided as follows: The reporter reported through online chat that, she had already reported it to the Center for disease control and prevention (CDC). Since the shot approximately 6 to 7 hours after, the patient began itchy and the itching continued and gotten worse and then a burning like a bad pair shoes. This was all over her body. Less than a month after receiving SHINGRIX, the patient did not had the rash but her antibodies were over 3000 since getting the shot. The patient would like to know what remedy was suggested for it. The patient had been dealing with this for almost over a month. The patient was seeing a neurologist at the time of reporting because she also got little shooting pains randomly throughout her body like little needles poking. The patient did not have rash though. Lab Comments: Lab test was done on an unknown date.
May 12, 2015 4 y/o received PROQUAD 5/12/2015. Returned 5/15/2015 swollen, redden at vaccine site.
Very sore left arm, all over body ache (including feet, legs, hands & fingers, jaw, etc.), dizziness, naseau, and fever
injection site tender with redness and swelling and hot to the touch 4x4.5cm , pt also developed swelling and pain over his left clavicle 3x3cm area-not red or hot to the touch
Saturday morning I woke up feeling fine. About an hour later I had a bad headache and my body started to be achy. That was followed by bilateral eye pain so that the only comfortable thing to do was to put on eye shades. I was exhausted by the afternoon. I had absolutely zero energy to do anything but lie down. By Sunday morning every inch of my skin was sensitive, every joint was sore  and every muscle group in my body was painful. The symptoms from the previous day remained; head and eye pain. I used both tylenol and advil a few times but without relief.  Monday my body/joints were still achy and I was super tired but not like the previous 2 days. I became very depressed and fearful that it would not let up. Today is Wednesday and its the first day I feel like myself again although I did have to take a nap 3 hours after I woke up today. Body still aches but nothing like it was
Swollen upper arm, redness, itching, pain, fatigue (all in vaccination area); onset was 10 days after immunization; this is the first day of onset of symptoms, no treatment prescribed
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 64-year-old female patient who received SHINGRIX for prophylaxis. On 9th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In June 2018, 30 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The batch number of SHINGRIX was not reported. The pharmacist notified by a patient that her physician had diagnosed her with Shingles. The patient had denied permission to contact their physician, as physician information was not known by the pharmacist.
Few hours after shot my arm felt a little sore. The next morning it was so sore I couldnt lift above my chest and needed  assistance dressing. That lasted all about 24 hrs.  4-5 days after initial shot, I noticed blotches on my chest, that led to me noticing a poker chip sized disk on my arm where the shot was given. It looked as if I had an implant of sorts in my arm. A bit itchy. It looked worse than what it was. That lasted about 2-3 days with benadryl. Some nauseous feelings would come and go but no vomiting or fever. Never went to a clinic to check it out. It went away on its own.
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Error: Wrong Needle Length-
Patient called me ~ 10 AM on 11/20/16 and stated she was concerned about her ZOSTAVAX injection she received on 11/18/16.  She was experiencing some redness, slight pain, and itching at the injection site.  I asked her if she had any other symptoms such as hives, breathing issues, large rash, or swollen arm - she stated no - just issue at the site itself, about 1.5 inches in diameter.  She felt fine other than discomfort at the site.  I told her she could use antihistamines oral or topical, and perhaps some pain relievers if needed.  She thanked me for the help and the advice, and I made she was ok to the best of my ability over the phone.  I called her back at ~ 2 pm on 11/20/16 to see how she was, and nothing really had changed - she was ok overall other than just discomfort at the injection site itself.  She thanked me for the follow up call, and all was ok.
See copy of medical records for initial visits.  Patient was admitted to hospital and still an inpatient as of 5/13/08.  DX: GBS.  Hospital progress notes also attached.  7/22/2008 MR received for DOS  3/03-5/23/2008 with D/C DX: Guillain-Barre Syndrome. 2ndary DX:  SIADH, constipation, R hand 5th metacarpal fracture and depression. Pt presented on 3/3/08 with 4 day hx of progressive ascending numbness and motor weakness which began at the ankles to the upper extremities. Pt developed respiratory distress and decreased vital capacity and was intubated on 3/09/08 x 7 days and extubated. No further respiratory issues. Tx with IVIG. Pt then developed SIADH and was tx with fluid restriction. Pt showed some sensation and motor function improvement although now c/o depression and continued pain in the feet. Choriform movements noted by neurology and tx with clonazapam with resolution of sx. Pt developed bilateral ankle contractures. D/C 5/23/08 to continue outpt rehab.
Feeling of itchy throat and coughing then started. Evaluated by EMT Gave 25 mg po Benadryl at 3:02PM.
RN observed patient holding head. Patient reporting frontal HA "mild" at this time. Also reporting dizziness. Wheelchair for patient to EMS room for patient to rest on cot. Water provided. Onset of HA approximately  15 minutes into observation. Pt rested - dizziness resolved quickly within a few minutes, Discharged at 1610 after escorting to BR.
Next day, felt fever, nausea, headache, tired, chills, sweating. Cough started in afternoon.    Two days later, felt fine upon waking up. Then felt lightheaded, heat in neck, then heat waves shooting down the body followed immediately by tingling. Happened all day to varying degrees and in varying limbs. Went to ER twice for this. They found nothing other than dehydration.
had to go to the Emergency room because he had a  reaction in his hand; everything that he touched hurted him,; extreme itchiness; hives,; everything that he touched hurted him, even in the eyes if he touched them; This spontaneous case was reported by a patient and describes the occurrence of LOCAL REACTION (had to go to the Emergency room because he had a  reaction in his hand), PAIN (everything that he touched hurted him,), PRURITUS (extreme itchiness), URTICARIA (hives,) and EYE PAIN (everything that he touched hurted him, even in the eyes if he touched them) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The patient had no allergies. The patient never had COVID positive test or diagnosis. The patient had no history of acute and chronic illnesses at the time of vaccination. The patient had not received other vaccines within 1 month prior to Moderna COVID-19 vaccine.    In 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced LOCAL REACTION (had to go to the Emergency room because he had a  reaction in his hand), PAIN (everything that he touched hurted him,), PRURITUS (extreme itchiness), URTICARIA (hives,) and EYE PAIN (everything that he touched hurted him, even in the eyes if he touched them). At the time of the report, LOCAL REACTION (had to go to the Emergency room because he had a  reaction in his hand), PAIN (everything that he touched hurted him,), PRURITUS (extreme itchiness), URTICARIA (hives,) and EYE PAIN (everything that he touched hurted him, even in the eyes if he touched them) had not resolved.            Concomitant medications was not provided by the reporter. On Nov2021 or Dec2021, the patient had to go to the emergency room  because he had a reaction in his hand, everything that he touched hurted him, and extreme itchiness, and hives, even in the eyes if he touched them. Patient controlled the symptoms with medication, but it did not cure him.   Reporter did not allow further contact
Injection site erythema (skin) burning and pain that hurts down to her Right hand. Pt is to ice and heat and continue CLARITIN and if gets worse to go to the ER.